Non-executive director Guo Huaqing increased his holdings of Keji Pharmaceutical (02171) by 18,000 shares at a price of HK$14.52 per share

The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on December 18, Guo Huaqing, a non-executive director, increased his holdings of Keji Pharmaceutical (02171) by 18,000 shares, at a price of HK$1,452 per share, for a total amount of about HK$261,400. The latest number of shares held after the increase was approximately 225 million shares, with a shareholding ratio of 39.01%.